Effects of Two Tumour Blood Flow Modifiers, Hydralazine and Flavone Acetic Acid, on KHT Tumours and Normal Tissues in Mice

By Honess D.J.   Bleehen N.M.  

International Journal of Radiation Biology, Vol. 60, Iss. 1-2, 1991-07 ,pp. : 249-253

Informa Healthcare

Access to resources Recommend Favorite

Monitoring Metabolic Responses after Induction of Hypoxia in the KHT Tumour Using ³¹P NMR Spectroscopy

By Bremner J.C.M.   Counsell C.J.R.   Edwards H.S.   Stratford I.J.   Adams G.E.   Nethersell A.B.W.   Bedford P.  

International Journal of Radiation Biology, Vol. 60, Iss. 1-2, 1991-07 ,pp. : 363-367

Informa Healthcare

Access to resources Recommend Favorite

Modulation of thalidomide pharmacokinetics by cyclophosphamide or 5,6-dimethylxanthenone-4-acetic acid (DMXAA) in mice: the role of tumour necrosis factor

By Chung Francisco   Wang Liang-Chuan   Kestell Philip   Baguley Bruce   Ching Lai-Ming  

Cancer Chemotherapy and Pharmacology, Vol. 53, Iss. 5, 2004-05 ,pp. : 377-383

Springer Publishing Company

Access to resources Recommend Favorite

The antitumour agent 5,6-dimethylxanthenone-4-acetic acid acts in vitro on human mononuclear cells as a co-stimulator with other inducers of tumour necrosis factor

By Philpott M.   Ching L.-M.   Baguley B.C.  

European Journal of Cancer, Vol. 37, Iss. 15, 2001-10 ,pp. : 1930-1937

Elsevier

Access to resources Recommend Favorite

Early Spatial and Temporal Changes in Tumour Perfusion after Administration of Flavone Acetic Acid

By Peters C.E.   Trotter M.J.   Chaplin D.J.  

International Journal of Radiation Biology, Vol. 60, Iss. 1-2, 1991-07 ,pp. : 341-348

Informa Healthcare

Access to resources Recommend Favorite